Susceptibility to Tumors Induced by Polyoma Virus is Conferred by an Endogenous Mouse Mammary Tumor Virus Superantigen
Overview
General Medicine
Affiliations
A dominant gene carried in certain inbred mouse strains confers susceptibility to tumors induced by polyoma virus. This gene, designated Pyvs, was defined in crosses between the highly susceptible C3H/BiDa strain and the highly resistant but H-2k-identical C57BR/cdJ strain. The resistance of C57BR/cdJ mice is overcome by irradiation, indicating an immunological basis. In F1 x C57BR/cdJ backcross mice, tumor susceptibility cosegregates with Mtv-7, a mouse mammary tumor provirus carried by the C3H/BiDa strain. This suggests that Pyvs might encode the Mtv-7 superantigen (SAG) and abrogate polyoma tumor immunosurveillance through elimination of T cells bearing specific V beta domains. DNA typing of 110 backcross mice showed no evidence of recombination between Pyvs and Mtv-7. Strongly biased usage of V beta 6 by polyoma virus-specific CD8+ cytotoxic T lymphocytes in C57BR/cdJ mice implicates T cells bearing this Mtv-7 SAG-reactive V beta domain as critical anti-polyoma tumor effector cells in vivo. These results indicate identity between Pyvs and Mtv-7 sag, and demonstrate a novel mechanism of inherited susceptibility to virus-induced tumors based on effects of an endogenous superantigen on the host's T cell repertoire.
Ye C, Clements S, Gu W, Geurts A, Mathews C, Serreze D Proc Natl Acad Sci U S A. 2023; 120(49):e2312039120.
PMID: 38015847 PMC: 10710095. DOI: 10.1073/pnas.2312039120.
Understanding polyomavirus CNS disease - a perspective from mouse models.
Ayers K, Carey S, Lukacher A FEBS J. 2021; 289(19):5744-5761.
PMID: 34145975 PMC: 8826653. DOI: 10.1111/febs.16083.
Hollern D, Swiatnicki M, Rennhack J, Misek S, Matson B, McAuliff A Sci Rep. 2019; 9(1):10718.
PMID: 31341204 PMC: 6656723. DOI: 10.1038/s41598-019-47218-0.
Qin Q, Shwetank , Frost E, Maru S, Lukacher A J Virol. 2016; 90(10):5187-99.
PMID: 26984726 PMC: 4859723. DOI: 10.1128/JVI.00199-16.
Holt M, Shevach E, Punkosdy G Front Oncol. 2013; 3:287.
PMID: 24324930 PMC: 3840357. DOI: 10.3389/fonc.2013.00287.